Experience With CHIMPS Endovascular Techniques and Outcomes in Comparison With Propensity-Matched Controls  by Novak, Zdenek et al.
JOURNAL OF VASCULAR SURGERY
Volume 59, Number 2 Abstracts 559patients, multivariate analysis showed HYBRID was associated with
signiﬁcantly higher rates of deep venous thrombosis/stroke (odds ratio,
13.6 vs 0.9; P ¼ .02) and prolonged intubation (odds ratio, 16.0 vs 1.8; P
¼ .003).
Conclusions: COPD patients should not be automatically excluded
from open TAR because the HYBRID procedure may not represent a safer
alternative.
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Objectives: Unsuitable endovascular anatomy presents a dilemma in
patients at high risk for open aortic aneurysm repair. We reviewed our expe-
rience with the off-label CHIMPS (CHIMney, Periscope, Snorkel)
approach to treat complex aortic aneurysms and deﬁne outcomes among
high-risk aortic aneurysm patients.
Methods: A retrospective analysis of all endovascular aortic proce-
dures performed between 2000 and 2013 was performed to identify patients
with CHIMPS endografts. CHIMPS patients were propensity-matched to
non-CHIMPS subjects by demographic and risk factors. Matched groups
were compared for outcomes. Signiﬁcance was statistically deﬁned using
c2 (or Fisher exact test), t-test, or Mann-Whitney U test. Kaplan-Meier
analysis was used to compare survival.
Results: The CHIMPS procedures were performed using 57 branch
stents in 38 patients (mean age, 71.9 6 13.8 years). CHIMPS were used
as initial endotherapy for 18 patients (47.3%). Indication for CHIMPS
included aneurysm diameter in 28 (mean 65 6 15 mm), rupture in 5, endo-
leak in 2, dissection in 1, dysphagia in 1, and mycotic aneurysm in 1.
Twenty-four procedures (63.1%) required stents in 1 vessel, 10 procedures
(26.3%) required 2 vessels, 3 procedures (7.8%) 3 vessels, and 1 procedure
(2.6%) required 4 vessels. Intraoperative endoleak was observed in 18 pa-
tients (47.3%): 12 with type I, 1 with type II, and 5 with type III. At 30
days, seven of these resolved and one additional type II endoleak was
observed. Of 57 total CHIMPS stents, four failed#30 days (three hypogas-
tric and one celiac). Two additional hypogastric CHIMPS stents failed
before the 12-month follow-up. No CHIMPS renal stents failed (n ¼
14). Thirty-day mortality was 10.5% (4 of 38) in nonemergency cases and
18.4% (7 of 38) with emergency cases, compared with 1.8% (2 of 114)
among matched EVAR patients. Among CHIMPS patients, two with
mesenteric stents and intentional exclusion of renals initiated hemodialysis.
Thirty-day glomerular ﬁltration rate estimates before and after procedures
did not differ signiﬁcantly between the groups. Kaplan-Meier analysis shows
decreased early survival but similar survival after 3 years in the matched
cohort.
Conclusions: The CHIMPS technique offers an alternative therapy in
patients with complex aneurysmal disease judged to be medically unsuitable
for open repair. Despite CHIMPS feasibility, these patients experience
increased mortality compared with a propensity-matched cohort.
Fig. Kaplan-Meier survival curves for patients treated using
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Objectives: Fenestrated endovascular aneurysm repair (FEVAR) has
become an alternative in patients unﬁt for open repair and with morphology
not suitable to traditional endovascular aneurysm repair (EVAR). FEVAR
requires cannulation and stent placement within visceral vessels that could
lead to complications not seen after traditional EVAR, and little is known
about the gastrointestinal complications (GICs). This study was performed
to determine the prevalence of GICs after FEVAR.
Methods: Over a 5-year period, we prospectively gathered data on
148 patients who underwent FEVAR at our institution.
Results: The median number of vessels fenestrated was three (inter-
quartile range [IQR], 2-4), with a total of 457 vessels. Minor and major
GICs occurred in 59 patients (39.9%). There were 2 (1.4%) gastrointestinal
bleeds, 2 patients (1.4%) who developed cholecystitis, 1 patient (0.7%) who
developed liver failure, and 2 patients (1.4%) who developed Clostridium
difﬁcile infections. No patients developed pancreatitis, ascites, or small
bowel obstructions. Seventy patients (47.3%) had a history of abdominal
complaints, and 24 (34.3%) of these developed a GIC. Seventy-two patients
(48.6%) had a history of abdominal surgery, and 24 (33.3%) of these devel-
oped a GIC. An ileus developed in 55 patients (37.2%), with 11 (7.4%)
requiring a nasogastric tube and three (2.0%) requiring total parenteral
nutrition. Five patients (3.4%) were taken to the operating room for pre-
sumed colonic ischemia, which was conﬁrmed in two patients (1.4%), and
one patient (0.7%) was found to have gangrenous cholecystitis. No patients
developed small bowel ischemia. The median time to tolerate a diet in the
GIC group was 5 days (IQR, 3-6 days). The median intensive care unit
stay was signiﬁcantly higher in the GIC group than in those without com-
plications (5 [IQR, 3-9] vs 2 [IQR, 1-3] days, respectively; P < .0001).
When comparing patients who had a complication based on extent of
visceral stenting, there was a higher rate in those who underwent stenting
of the celiac artery compared with those that only included the renal arteries
(13 of 40 vs 27 of 56; P ¼ .003) and a higher complication rate comparing
above and below the SMA (13 of 40 [32.5%] vs 46 of 108 [42.6%]; P ¼
.002). Fourteen patients (9.5%) required readmission #30 days, nine
(6.1%) for a GIC, although none required surgical intervention.
Conclusions: Serious GICs after FEVAR are rare. However, ileus and
delayed return of bowel function are common and a major cause of
extended hospital stay. Not surprisingly, the level of complexity of FEVAR
appears to inﬂuence GIC rates.
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Objectives: This study measured changes in aortic diameter and vol-
ume after aneurysm repair using a multibranched thoracoabdominal stent
graft.
Method: Between September 2005 and May 2013, 120 patients un-
derwent aneurysm repair using multibranched thoracoabdominal stent
grafts. Follow-up included routine computed tomography (CT) at 1, 6,
and 12 months and yearly thereafter. We retrospectively compared the
initial postoperative CT angiography (CTA) with subsequent CTA using
three-dimensional analysis to measure changes in the maximum diameter
of the aneurysm and the volume of aorta encompassed by the stent graft.
Results: In 91 patients the CTA was adequate for serial measurement
of aneurysm diameter. Mean follow-up was 23.05 6 17.37 months.
Comparing the ﬁrst CTA with the most recent CTA, 52 patients
(57.14%) had >5-mm diameter decrease, 39 (42.86%) had <5-mm change,
and none had >5-mm increase. The CTA in 47 patients was adequate for
serial measurement of aortic volume. Of these, 35 (74.47%) had >5%
decreased in aortic volume, nine (19.15%) had <5% change, and three
(6.38%) had >5% increase. In the same group of 47 patients, diameter
decreased in 32 (68%) and remained stable in 15 (32%). This small differ-
ence in the frequency of aneurysm size change (up or down) between vol-
ume-based and diameter-based measurements was not signiﬁcant. The
correlation between volume change and diameter change was signiﬁcant
(P ¼ .006) but weak (R2 ¼ 0.16). Twenty-six patients (28.5%) had 30
endoleaks (type I, 6; type II, 19; type III, 5). The prevalence of diameter
decrease was slightly lower in patients with endoleaks than patients without.
The effect of endoleak on diameter might have been more signiﬁcant had
direct endoleaks (types I and III) not been treated. In three cases, endoleak
